Skip to Content
Merck
  • A de novo mutation affecting human TrkB associated with severe obesity and developmental delay.

A de novo mutation affecting human TrkB associated with severe obesity and developmental delay.

Nature neuroscience (2004-10-21)
Giles S H Yeo, Chiao-Chien Connie Hung, Justin Rochford, Julia Keogh, Juliette Gray, Shoba Sivaramakrishnan, Stephen O'Rahilly, I Sadaf Farooqi
ABSTRACT

An 8-year-old male with a complex developmental syndrome and severe obesity was heterozygous for a de novo missense mutation resulting in a Y722C substitution in the neurotrophin receptor TrkB. This mutation markedly impaired receptor autophosphorylation and signaling to MAP kinase. Mutation of NTRK2, which encodes TrkB, seems to result in a unique human syndrome of hyperphagic obesity. The associated impairment in memory, learning and nociception seen in the proband reflects the crucial role of TrkB in the human nervous system.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
TrkB/Fc Chimera human, >90% (SDS-PAGE), recombinant, expressed in NSO cells, lyophilized powder